Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with stage 3 or stage 5 chronic kidney disease (meaning their kidneys are working at a reduced level, with a specific kidney function score between 15 and 59)
- People who have been receiving nutrition treatment as an outpatient for at least 6 months
- People who have been on regular kidney dialysis (hemodialysis) for at least 6 months
- People who are taking between one and three medications to control blood pressure
Who may not be able to join:
- People who have an autoimmune condition or an active infectious disease
- People who have diabetes
- People who have or have had cancer
- People who have HIV/AIDS
- People who are pregnant
- People who are currently taking steroids, other medications that break down muscle or body tissue, or antibiotics
- People who access dialysis through a catheter (a tube inserted into a vein), rather than through a surgically created access point in the arm
- People who are currently taking antioxidant vitamin supplements, prebiotics, probiotics, or symbiotic supplements
- People who regularly take propolis (a natural bee product) and are allergic to corn starch, or who report being allergic to bee stings
- People who have recently had a heart attack or a stroke
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Denise Mafra, PhD, Universidade Federal Fluminense
Phone: 5521985683003
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in factor nuclear kappaB; Change in intestinal microbiota
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.